미국 · 보도자료 · ANGO · 2026-10-08 10:02
2027 회계연도 1분기 실적 발표, 의료 기술 성장과 수익성 개선 지속
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2027, which ended August 31, 2026. Fiscal Year 2027 Fir
